Date: 2017-11-06
Type of information: Opening of new premises
Compound: U.K. headquarters
Company: Adaptimmune (UK)
Therapeutic area: Cancer - Oncology
Type agreement: opening of new premises
Action mechanism:
Disease:
Details:
- • On November 6, 2017, Adaptimmune Therapeutics has hosted the official opening ceremony at its new U.K. headquarters in Oxfordshire. Over 400 people, including employees and senior representatives from the regional and national business, academic, government and investor communities, gathered to celebrate the official opening of the flagship facility.
- Adaptimmune’s state-of-the-art 67,000 square foot building comprises laboratory and office space and is designed to accommodate all of the company’s U.K. research and development operations and corporate teams. This facility at Milton Park, Oxfordshire, complements Adaptimmune’s newly built U.S. headquarters and clinical and manufacturing operations at the Navy Yard in Philadelphia.
Financial terms:
Latest news:
Is general: Yes
